Glatiramer Acetate in the Reduction of Relapse Frequency in Multiple Sclerosis

被引：0

作者：

Miravalle, Augusto ^{[2
]}

Hendin, Barry ^{[3
]}

Vollmer, Timothy L. ^{[2
]}

Kala, Mrinalini ^{[1
,3
]}

机构：

[1] St Josephs Hosp, Barrow Neurol Inst, Div Neurol, 350 West Thomas Rd, Phoenix, AZ 85013 USA

[2] Univ Colorado Hlth Sci, Dept Neurol, Aurora, CO 80045 USA

[3] Univ Arizona, Coll Med, Phoenix, AZ USA

来源：

CLINICAL MEDICINE INSIGHTS-THERAPEUTICS | 2011年 / 3卷

关键词：

multiple sclerosis; glatiramer acetate; relapse rate;

D O I：

10.4137/CMT.S2057

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Glatiramer acetate (GA; Copaxone (R)) is a heterogeneous polymer of four amino acids. It is one of the therapies approved by the Food and Drug Administration in 1996 for treatment of relapsing remitting multiple sclerosis (RRMS). GA reduces the relapse rate for RRMS, and has a good safety profile and moderate efficacy. Preclinical and clinical studies reveal that GA plays a role in modulating the cells of the immune system as well as in neuroprotection. In this article, we review the role of GA in reducing the frequency of relapses in MS, as well as its efficacy, safety, and current place in therapy.

引用

页码：151 / 158

页数：8

共 68 条

[1] EFFECT OF A SYNTHETIC POLYPEPTIDE (COP 1) ON PATIENTS WITH MULTIPLE-SCLEROSIS AND WITH ACUTE DISSEMINATED ENCEPHALOMYELITIS [J].

ABRAMSKY, O ;

TEITELBAUM, D ;

ARNON, R .

JOURNAL OF THE NEUROLOGICAL SCIENCES, 1977, 31 (03) :433-438

[2] The immunomodulator glatiramer acetate augments the expression of neurotrophic factors in brains of experimental autoimmune encephalomyelitis mice [J].

Aharoni, R ;

Eilam, R ;

Domev, H ;

Labunskay, G ;

Sela, M ;

Arnon, R .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (52) :19045-19050

[3] Neurogenesis and neuroprotection induced by peripheral immunomodulatory treatment of experimental autoimmune encephalomyelitis [J].

Aharoni, R ;

Arnon, R ;

Eilam, R .

JOURNAL OF NEUROSCIENCE, 2005, 25 (36) :8217-8228

[4] Glatiramer acetate-specific T cells in the brain express T helper 2/3 cytokines and brain-derived neurotrophic factor in situ [J].

Aharoni, R ;

Kayhan, B ;

Eilam, R ;

Sela, M ;

Arnon, R .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (24) :14157-14162

[5] Demyelination arrest and remyelination induced by glatiramer acetate treatment of experimental autoimmune encephalomyelitis [J].

Aharoni, Rina ;

Herschkovitz, Avia ;

Eilam, Raya ;

Blumberg-Hazan, Michal ;

Sela, Michael ;

Bruck, Wolfgang ;

Arnon, Ruth .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (32) :11358-11363

[6] Glatiramer acetate reduces Th-17 inflammation and induces regulatory T-cells in the CNS of mice with relapsing-remitting or chronic EAE [J].

Aharoni, Rina ;

Eilam, Raya ;

Stock, Ariel ;

Vainshtein, Anya ;

Shezen, Elias ;

Gal, Hilah ;

Friedman, Nir ;

Arnon, Ruth .

JOURNAL OF NEUROIMMUNOLOGY, 2010, 225 (1-2) :100-111

[7] Splenic natural killer cell activity in two models of experimental neurodegenerative diseases [J].

Al-Falahi, Yassin ;

Sand, Kristin L. ;

Knudsen, Eirunn ;

Damaj, Bassam B. ;

Rolin, Johannes ;

Maghazachi, Azzam A. .

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2009, 13 (8B) :2693-2703

[8] Mechanism of action of glatiramer acetate in multiple sclerosis and its potential for the development of new applications [J].

Arnon, R ;

Aharoni, R .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 :14593-14598

[9] Lower brain-derived neurotrophic factor in serum of relapsing remitting MS: Reversal by glatiramer acetate [J].

Azoulay, D ;

Vachapova, V ;

Shihman, B ;

Miler, A ;

Karni, A .

JOURNAL OF NEUROIMMUNOLOGY, 2005, 167 (1-2) :215-218

[10] Serial combination therapy: is immune modulation in multiple sclerosis enhanced by initial immune suppression? [J].

Bar-Or, A. ;

Oger, J. ;

Gibbs, E. ;

Niino, M. ;

Aziz, T. ;

Renoux, C. ;

Alatab, S. ;

Shi, F. D. ;

Campagnolo, D. ;

Jalili, F. ;

Rhodes, S. ;

Yamashita, T. ;

Fan, B. ;

Freedman, M. S. ;

Panitch, H. ;

Arnold, D. L. ;

Vollmer, T. .

MULTIPLE SCLEROSIS JOURNAL, 2009, 15 (08) :959-964

← 1 2 3 4 5 6 7 →